Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS4 | Q9NRS4 | 13/20 | 0.73 |
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.60 |
| ▸ | P2RX4 | Q99571 | 3/20 | 0.60 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | IKBKB | O14920 | 1/20 | 0.60 |
| ▸ | CHUK | O15111 | 1/20 | 0.60 |
| ▸ | KDR | P35968 | 1/20 | 0.60 |
| ▸ | FLT3 | P36888 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | MYLK | Q15746 | 1/20 | 0.60 |
| ▸ | MAP4K5 | Q9Y4K4 | 1/20 | 0.60 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.60 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.56 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.56 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30771738 | 1.00 | TMPRSS4 (0.73) | TMPRSS4KCNMA1KDM4EP2RX1P2RX4 | |
| SCHEMBL4264823 | 0.89 | TMPRSS4 (0.72) | TMPRSS4KCNMA1KDM4EP2RX1P2RX4 | |
| SCHEMBL14886017 | 0.88 | TMPRSS4 (0.65) | TMPRSS4KCNMA1KDM4EP2RX1P2RX4 | |
| SCHEMBL330187 | 0.88 | TMPRSS4 (0.65) | TMPRSS4KCNMA1P2RX1P2RX4P2RX7 | |
| SCHEMBL330371 | 0.87 | TMPRSS4 (0.68) | TMPRSS4KCNMA1P2RX1P2RX4P2RX7 | |
| SCHEMBL330413 | 0.84 | TMPRSS4 (1.00) | TMPRSS4KCNMA1P2RX1P2RX4P2RX7 | |
| SCHEMBL5066868 | 0.84 | TMPRSS4 (0.81) | TMPRSS4KCNMA1KDM4EP2RX1P2RX4 | |
| SCHEMBL28109668 | 0.83 | SMN1; SMN2 (0.70) | KCNMA1KDM4EP2RX1P2RX4P2RX7 | |
| SCHEMBL1704851 | 0.83 | TMPRSS4 (0.67) | TMPRSS4KCNMA1KDM4EP2RX1P2RX4 | |
| SCHEMBL1462989 | 0.82 | GRIK1 (0.72) | TMPRSS4KCNMA1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240002332-A1 | Small Molecule Inhibitors of SARS-CoV-2 Infections | THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION | 2024-01-04 | — | — | US | claimed |
| EP-3653303-B1 | PIPETTE TIP RACK | BIOTIX INC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-12201987-B2 | Pipette tip rack | BIOTIX, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-20240002332-A1 | Small Molecule Inhibitors of SARS-CoV-2 Infections | THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION | 2024-01-04 | — | — | US | disclosed |
| US-11590490-B2 | Pipette tips | BIOTIX, INC. (US) | 2023-02-28 | — | — | US | disclosed |
| WO-2022109148-A1 | SMALL MOLECULE INHIBITORS OF SARS-COV-2 INFECTIONS | THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2022-05-27 | — | — | WO | disclosed |
| EP-3628404-B1 | PIPETTE TIP TRAYS | BIOTIX INC (US) | 2021-06-30 | — | — | EP | disclosed |
| EP-3831489-A1 | PIPETTE TIPS | Biotix, Inc. (US) | 2021-06-09 | — | — | EP | disclosed |
| US-20210039086-A1 | PIPETTE TIPS | BIOTIX, INC. | 2021-02-11 | — | — | US | disclosed |
| US-20210016290-A1 | PIPETTE TIP RACK | BIOTIX, INC. | 2021-01-21 | — | — | US | disclosed |
| EP-1458419-A1 | ANTIMICROBIAL CONTACT LENS CASE | Novartis AG (CH) | 2004-09-22 | — | — | EP | disclosed |
| EP-1352650-A1 | INHIBITORS AGAINST THE PRODUCTION AND RELEASE OF INFLAMMATORY CYTOKINES | Institute of Medicinal Molecular Design, Inc. (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-20030176530-A1 | Antimicrobial contact lens case | LINDLEY KAREN FRANCES (US) | 2003-09-18 | — | — | US | disclosed |
| WO-2003049776-A1 | ANTIMICROBIAL CONTACT LENS CASE | NOVARTIS AG (CH) | 2003-06-19 | — | — | WO | disclosed |
| US-20030108761-A1 | Anti-bacterial paper products | EDDLEMON TAMMY (US) | 2003-06-12 | — | — | US | disclosed |
| WO-2001070189-A1 | METHOD AND COMPOSITION FOR SKIN LIGHTENING APPLYING CARBOXYLIC ACIDS | UNILEVER PLC (GB) | 2001-09-27 | — | — | WO | disclosed |
| US-6138315-A | Antimicrobial active compounds | CHESEBROUGH-POND'S USA CO., DIVISON OF CONOPCO, INC. (US) | 2000-10-31 | — | — | US | disclosed |
| US-5919152-A | Antibacterial swabs | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1999-07-06 | — | — | US | disclosed |
| US-5846215-A | Antibacterial swabs | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1998-12-08 | — | — | US | disclosed |
| US-4022880-A | ZINC IONS, 3,4,5-TRIBROMO-SALICYLANILIDE, QUATERNARY AMMONIUM COMPOUNDS | LEVER BROTHERS COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002332-A1 | Small Molecule Inhibitors of SARS-CoV-2 Infections | ACE2, ACE, TMPRSS2 | TMPRSS4 14/4885KCNMA1 3777/4885KDM4E 3140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.